Crohn’s disease and ulcerative colitis are inflammatory diseases without a single cause. A genetic predisposition and environmental risk factors contribute to developement of the disease.
IBD are caused by an inadequate response of the immune system to the normal, nonpathogenic intestinal bacteria resulting in intestinal damage. The gut microbiome of patients shows alterations. The intestinal barrier is impaired.
Environmental factors seem to play a variable role. Smoking has negative impact on Crohn’s disease.
UC is limited to the colon. CD may involve any part of the intestinal tract and is characterized by transmural inflammation, formation of stenoses, and fistulae.
While the bowel is the main place of manifestation, various other parts of the body may also be affected (extraintestinal manifestations, EIM).
Genetic susceptibility Environmental factors Disruption of intestinal barrier Dysregulation of immune system Dysbiosis of microbiome Extraintestinal manifestations Fistula Stenoses
This is a preview of subscription content, log in to check access.
Baumgart DC, Carding SR (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369(9573):1627–1640CrossRefGoogle Scholar
Gordon H, Moller FT, Andersen V, Harbord M (2015) Heritability in inflammatory bowel disease: from the first twin study to genome-wide association studies. Inflamm Bowel Dis 21(6):1428–1434PubMedPubMedCentralGoogle Scholar
Kim ER, Chang DK (2014) Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol 20(29):9872–9881CrossRefGoogle Scholar
Rieder F, Fiocchi C, Rogler G (2017) Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology 152(2):340–350CrossRefGoogle Scholar
Scharl M, Rogler G (2014) Pathophysiology of fistula formation in Crohn’s disease. World J Gastrointest Pathophysiol 5(3):205–212CrossRefGoogle Scholar
Calvin Coffey J, Peter O’Leary D (2016) The mesentery: structure, function, and role in disease. Lancet Gastroenterol Hepatol 1(3):238–247CrossRefGoogle Scholar
Silverberg MS, Satsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5A–36ACrossRefGoogle Scholar
Pariente B, Cosnes J, Danese S et al (2011) Development of the Crohn’s disease digestive damage score, the Lémann score. Inflamm Bowel Dis 17(6):1415–1422CrossRefGoogle Scholar